Lixia Dong

483 total citations
15 papers, 325 citations indexed

About

Lixia Dong is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lixia Dong has authored 15 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lixia Dong's work include RNA modifications and cancer (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer-related molecular mechanisms research (3 papers). Lixia Dong is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer-related molecular mechanisms research (3 papers). Lixia Dong collaborates with scholars based in China and Australia. Lixia Dong's co-authors include Yanyun Zhang, Feng-Mao An, Guowei Zhang, Jie Cao, Yu Liu, Kui Wang, Mao Wang, Xingyun Wu, Yu Liu and Shuang Liu and has published in prestigious journals such as Nature Communications, Archives of Biochemistry and Biophysics and Cell Cycle.

In The Last Decade

Lixia Dong

15 papers receiving 324 citations

Peers

Lixia Dong
Binshan Zha China
Chunlei Liu China
Pixiong Su China
Kyoko Tanimura Japan
Pang‐Bo Li China
Hongmu Li China
Simone Gorreßen Germany
Jayakumar Manoharan Germany
Chufeng Gu China
Mi Yeon Kang South Korea
Binshan Zha China
Lixia Dong
Citations per year, relative to Lixia Dong Lixia Dong (= 1×) peers Binshan Zha

Countries citing papers authored by Lixia Dong

Since Specialization
Citations

This map shows the geographic impact of Lixia Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixia Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixia Dong more than expected).

Fields of papers citing papers by Lixia Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixia Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixia Dong. The network helps show where Lixia Dong may publish in the future.

Co-authorship network of co-authors of Lixia Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Lixia Dong. A scholar is included among the top collaborators of Lixia Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixia Dong. Lixia Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Luo, Li, Xingyun Wu, Lixia Dong, et al.. (2024). FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma. Nature Communications. 15(1). 4790–4790. 29 indexed citations
3.
Wang, Kui, Li Luo, Mao Wang, et al.. (2023). PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma. Nature Communications. 14(1). 1011–1011. 74 indexed citations
4.
Yan, Yani, Cong Liu, Jian Zhang, et al.. (2021). SMC4 knockdown inhibits malignant biological behaviors of endometrial cancer cells by regulation of FoxO1 activity. Archives of Biochemistry and Biophysics. 712. 109026–109026. 13 indexed citations
5.
Liu, Cong, et al.. (2021). Inhibition of NCAPG expression inactivates the Wnt/β‐catenin signal to suppresses endometrial cancer cell growth in vitro. Environmental Toxicology. 36(12). 2512–2520. 11 indexed citations
6.
7.
Zhang, Qian, et al.. (2021). Application of metagenomic next-generation sequencing (mNGS) combined with rapid on-site cytological evaluation (ROSCE) for the diagnosis of Chlamydia psittaci pneumonia.. International Journal of Clinical and Experimental Pathology. 14(4). 389–398. 5 indexed citations
8.
Dong, Lixia, et al.. (2021). LncRNA NEAT1 promotes Alzheimer's disease by down regulating micro-27a-3p.. American Journal of Translational Research. 13(8). 8885–8896. 39 indexed citations
9.
Liu, Shuang, Min Liu, & Lixia Dong. (2020). The clinical value of lncRNA MALAT1 and its targets miR‐125b, miR‐133, miR‐146a, and miR‐203 for predicting disease progression in chronic obstructive pulmonary disease patients. Journal of Clinical Laboratory Analysis. 34(9). e23410–e23410. 18 indexed citations
10.
11.
Dong, Lixia, et al.. (2018). Pulmonary Embolism in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Chinese Medical Journal. 131(14). 1732–1737. 31 indexed citations
12.
Dong, Lixia, Linlin Sun, Xia Zhang, et al.. (2012). Negative regulation of mTOR activity by LKB1-AMPK signaling in non-small cell lung cancer cells. Acta Pharmacologica Sinica. 34(2). 314–318. 38 indexed citations
13.
Chen, Bao-yuan, et al.. (2011). [The effect of intermittent hypoxia with different degrees and frequencies on levels of superoxide dismutases and malondialdehyde in vascular endothelial cells].. PubMed. 34(5). 371–4. 1 indexed citations
14.
Chen, Bao-yuan, et al.. (2010). [Effect of different intermittent hypoxia patterns on interleukin-6 and interleukin-8 levels of human umbilical vein endothelial cells].. PubMed. 45(2). 139–42. 1 indexed citations
15.
Yuan, Zhiming, et al.. (2004). [Changes of angiotensin II and its receptor during the development of chronic intermittent hypoxia-induced hypertension in rats].. PubMed. 27(9). 577–80. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Binshan Zha Breakdown of academic impact, for papers by Chunlei Liu Breakdown of academic impact, for papers by Pixiong Su Breakdown of academic impact, for papers by Kyoko Tanimura Breakdown of academic impact, for papers by Pang‐Bo Li Breakdown of academic impact, for papers by Hongmu Li Breakdown of academic impact, for papers by Simone Gorreßen Breakdown of academic impact, for papers by Jayakumar Manoharan Breakdown of academic impact, for papers by Chufeng Gu Breakdown of academic impact, for papers by Mi Yeon Kang
Rankless by CCL
2026